Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment develops, manufactures, and distributes rigid bracing products, orthopedic soft goods, vascular systems and compression garments, and hot and cold therapy products and offers recovery sciences products in the clinical rehabilitation and sports medicine markets, such as bone growth stimulators and electrical stimulators used for pain management. The Reconstructive segment develops, manufactures, and markets a variety of knee, hip, shoulder, elbow, foot, ankle, and finger implant products and surgical productivity tools. It also provides Novastep, a minimally invasive surgery (MIS) foot and ankle solutions.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļENOV
āļāļ·āđāļāļāļĢāļīāļĐāļąāļEnovis Corp
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļMay 08, 2008
āļāļĩāļāļĩāđāļMr. Damien Mcdonald
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ7367
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļMay 08
āļāļĩāđāļāļĒāļđāđ2711 Centerville Road
āđāļĄāļ·āļāļWILMINGTON
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNYSE Consolidated
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ19808
āđāļāļĢāļĻāļąāļāļāđ13022529160
āđāļ§āđāļāđāļāļāđhttps://www.enovis.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļENOV
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļMay 08, 2008
āļāļĩāļāļĩāđāļMr. Damien Mcdonald
Mr. Daniel Alexis Pryor
Executive Vice President - Strategy and Business Development
Executive Vice President - Strategy and Business Development
Mr. Damien Mcdonald
Chief Executive Officer, Director
Chief Executive Officer, Director
Mr. Terry D. Ross
Group President - Prevention and Recovery
Group President - Prevention and Recovery
Ms. Sharon L. Wienbar
Independent Chairman of the Board
Independent Chairman of the Board
Mr. Rajiv Vinnakota
Independent Director
Mr. Liam J. Kelly
Independent Director
Ms. Barbara W. Bodem
Independent Director
Dr. Christine Ortiz, Ph.D.
Dr. Christine Ortiz, Ph.D.
Independent Director
Mr. Philip A. Okala
Independent Director
Ms. Angela S. Lalor
Independent Director
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Mr. Daniel Alexis Pryor
Executive Vice President - Strategy and Business Development
Executive Vice President - Strategy and Business Development
Mr. Damien Mcdonald
Chief Executive Officer, Director
Chief Executive Officer, Director
Mr. Terry D. Ross
Group President - Prevention and Recovery
Group President - Prevention and Recovery
Ms. Sharon L. Wienbar
Independent Chairman of the Board
Independent Chairman of the Board
Mr. Rajiv Vinnakota
Independent Director
Mr. Liam J. Kelly
Independent Director
SPDR S&P Health Care Equipment ETF
Invesco S&P SmallCap Health Care ETF
Invesco S&P SmallCap 600 Pure Value ETF
VictoryShares US Small Mid Cap Value Momentum ETF
SPDR S&P 600 Small Cap Value ETF
First Trust Small Cap Growth AlphaDEX Fund
iShares S&P Small-Cap 600 Value ETF
Avantis US Small Cap Equity ETF
iShares U.S. Medical Devices ETF
SPDR S&P SmallCap 600 ESG ETF
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
SPDR S&P Health Care Equipment ETF
āļŠāļąāļāļŠāđāļ§āļ1.72%
Invesco S&P SmallCap Health Care ETF
āļŠāļąāļāļŠāđāļ§āļ1.03%
Invesco S&P SmallCap 600 Pure Value ETF
āļŠāļąāļāļŠāđāļ§āļ0.5%
VictoryShares US Small Mid Cap Value Momentum ETF
āļŠāļąāļāļŠāđāļ§āļ0.31%
SPDR S&P 600 Small Cap Value ETF
āļŠāļąāļāļŠāđāļ§āļ0.28%
First Trust Small Cap Growth AlphaDEX Fund
āļŠāļąāļāļŠāđāļ§āļ0.27%
iShares S&P Small-Cap 600 Value ETF
āļŠāļąāļāļŠāđāļ§āļ0.24%
Avantis US Small Cap Equity ETF
āļŠāļąāļāļŠāđāļ§āļ0.21%
iShares U.S. Medical Devices ETF
āļŠāļąāļāļŠāđāļ§āļ0.2%
SPDR S&P SmallCap 600 ESG ETF
āļŠāļąāļāļŠāđāļ§āļ0.19%
āļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
0.00
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē

āđāļĄāđāļĄāļĩāļāđāļāļĄāļđāļĨ